0001493152-21-005282.txt : 20210303
0001493152-21-005282.hdr.sgml : 20210303
20210303162539
ACCESSION NUMBER: 0001493152-21-005282
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210210
FILED AS OF DATE: 20210303
DATE AS OF CHANGE: 20210303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lisi Steven A.
CENTRAL INDEX KEY: 0001702628
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38892
FILM NUMBER: 21709310
MAIL ADDRESS:
STREET 1: 2 ILAN RAMON, SCIENCE PARK
CITY: NESS ZIONA
STATE: L3
ZIP: 7403635
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Beyond Air, Inc.
CENTRAL INDEX KEY: 0001641631
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 473812456
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 825 EAST GATE BOULEVARD, SUITE 320
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
BUSINESS PHONE: 516-665-8200
MAIL ADDRESS:
STREET 1: 825 EAST GATE BOULEVARD, SUITE 320
CITY: GARDEN CITY
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: AIT Therapeutics, Inc.
DATE OF NAME CHANGE: 20170117
FORMER COMPANY:
FORMER CONFORMED NAME: KokiCare, Inc.
DATE OF NAME CHANGE: 20150507
4/A
1
ownership.xml
X0306
4/A
2021-02-10
2021-02-12
0
0001641631
Beyond Air, Inc.
XAIR
0001702628
Lisi Steven A.
C/O BEYOND AIR, INC.
825 EAST GATE BOULEVARD, SUITE 320
GARDEN CITY
NY
11530
1
1
0
0
CEO and Chairman of the Board
Common Stock
2021-02-10
4
M
0
117112
4.25
A
1051875
D
Common Stock
2021-02-10
4
F
0
70388
7.0713
D
981487
D
Tranche B Warrant (right to buy)
4.25
2021-02-10
4
M
0
117112
0
D
2018-02-16
2021-02-16
Common Stock
117112
0
D
On February 10, 2021, the reporting person exercised a warrant to purchase 117,112 shares of common stock, par value $0.0001 per share, of Beyond Air, Inc. (the "Company") for $4.25 a share. The reporting person paid the exercise price on a cashless basis, resulting in the Company's withholding of 70,388 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 46,724 shares of common stock of the Company.
This Form 4/A amends the Form 4 filed on February 12, 2021 (the "Original Form 4") solely to change the transaction codes in (i) row 1 of Tables I and II from "X" to "M" and (ii) row 2 of Table I from "S" to "F", in each case, to more clearly convey that the reported transactions were exempt from Section 16(b) in accordance with Rule 16b-3.
/s/ Steven A. Lisi
2021-03-03